EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 -1.038
March 31, 2026 -0.3734
December 31, 2025 -0.4942
September 30, 2025 -0.7277
June 30, 2025 -0.7717
March 31, 2025 -0.5296
December 31, 2024 -0.3016
September 30, 2024 -0.2172
June 30, 2024 -0.2471
March 31, 2024 -0.2642
December 31, 2023 -0.3275
September 30, 2023 -0.1784
June 30, 2023 -0.148
March 31, 2023 -0.1949
December 31, 2022 -0.4897
September 30, 2022 -0.9476
June 30, 2022 -0.6744
March 31, 2022 -0.4926
December 31, 2021 -0.5457
September 30, 2021 -0.4288
June 30, 2021 -0.3273
Date Value
March 31, 2021 -0.2934
December 31, 2020 -0.3098
September 30, 2020 0.0702
June 30, 2020 -0.4345
March 31, 2020 -0.412
December 31, 2019 -0.391
September 30, 2019 -0.3707
June 30, 2019 -0.455
March 31, 2019 -0.4194
December 31, 2018 -0.3953
September 30, 2018 -0.3469
June 30, 2018 -0.3354
March 31, 2018 -0.3305
December 31, 2017 -1.06
September 30, 2017 -0.3548
June 30, 2017 -0.3734
March 31, 2017 -0.3436
December 31, 2016 -0.3865
September 30, 2016 -0.3038
June 30, 2016 -0.3359
March 31, 2016 -0.256

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. 1.279
Bio-Rad Laboratories, Inc. 13.85
Bruker Corp. -0.413
Azenta, Inc. 0.0542
Danaher Corp. 1.230